Related Experiment Video
Updated: Sep 28, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway
Wanli Zhang1, Weikuan Sun1, Xiaofan Gu1
1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
Abstract:
Tumor-derived exosomes are emerging mediators of cancer cachexia, a kind of multifactorial syndrome characterized by serious loss of skeletal muscle mass and function. Our previous study had showed that microRNAs in exosomes of C26 colon tumor cells were involved in induction of muscle atrophy. Here, we focus on studying proteins in tumor-derived exosomes which might also contribute to the development of cancer cachexia. Results of comparing the protein profiles of cachexic C26 exosomes and non-cachexic MC38 exosomes suggested that growth differentiation factor 15 (GDF-15) was rich in C26 exosomes. Western blotting analysis confirmed the higher levels of GDF-15 in C26 cells and C26 exosomes, compared with that of MC38 cells. Results of animal study also showed that GDF-15 was rich in tumor tissues, serum exosomes, and gastrocnemius (GA) muscle tissues of C26 tumor-bearing mice. GDF-15 protein could directly induce muscle atrophy of cultured C2C12 myotubes via regulating Bcl-2/caspase-3 pathways. What's more, overexpression of GDF-15 in MC38 cells could increase the potency of MC38 conditioned medium or exosomes in inducing muscle atrophy. Knockdown of GDF-15 in C26 cells decreased the potency of C26 conditioned medium or exosomes in inducing muscle atrophy. These results suggested that GDF-15 in tumor-derived exosomes could contribute to induction of muscle atrophy and also supported the possibility of targeting GDF-15 in treatment of cancer cachexia.
Insights
Growth differentiation factor 15 (GDF-15) in tumor exosomes promotes cancer cachexia by inducing muscle atrophy. Targeting GDF-15 may offer a therapeutic strategy for this debilitating condition.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer cachexia is a complex syndrome causing significant muscle loss.
- Tumor-derived exosomes are implicated in cancer cachexia pathogenesis.
- Previous research identified microRNAs in exosomes contributing to muscle atrophy.
Purpose of the Study:
- To investigate the role of proteins within tumor-derived exosomes in cancer cachexia.
- To identify specific exosomal proteins that induce muscle atrophy.
Main Methods:
- Comparative proteomic analysis of exosomes from cachectic (C26) and non-cachectic (MC38) tumor cells.
- Western blotting to validate protein expression levels.
- In vitro studies using C2C12 myotubes to assess GDF-15's direct effects.
- In vivo studies in tumor-bearing mice.
- Genetic manipulation (overexpression and knockdown) of GDF-15 in cancer cells.
Main Results:
- Growth differentiation factor 15 (GDF-15) was significantly elevated in exosomes from cachectic C26 tumor cells compared to non-cachectic MC38 cells.
- GDF-15 directly induced muscle atrophy in cultured myotubes by modulating Bcl-2/caspase-3 pathways.
- Overexpression of GDF-15 enhanced the muscle-atrophying potential of tumor-derived factors, while its knockdown reduced this potential.
- GDF-15 was also found in tumor tissues, serum exosomes, and muscle tissues of tumor-bearing mice.
Conclusions:
- GDF-15, present in tumor-derived exosomes, plays a crucial role in inducing muscle atrophy associated with cancer cachexia.
- GDF-15 represents a potential therapeutic target for managing cancer cachexia.
More Related Videos
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
The Intrinsic Apoptotic Pathway